Gilead Sciences has grown revenue 3.6% a year over three years and 2.7% a year over five, with earnings per share compounding at 23%. Revenue growth, 3-year annual rate: +3.6% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +2.7%, growth has picked up over the last three years. Earnings per share, 3-year rate: +23%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

GILDGilead Sciences

HealthcareUSD

$148.13

$107.4852 weeks$153.91

Is it growing?

Is GILD growing?

Gilead Sciences has grown revenue 3.6% a year over three years and 2.7% a year over five, with earnings per share compounding at 23%.

+3.6%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +2.7%
Revenue growth, 5-year rate · +3.6% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +23%
Earnings per share, 3-year rate · revenue +3.6% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed